NOVT
Novanta Inc.
NOVT trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over NOVT overall, supported by stronger valuation and stronger fundamentals.
NOVT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Weak |
NOVT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
NOVT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 72x | $94.82 | -19% |
| Fair | 86x | $113 | -3.6% |
| Current | 89x | $117 | — |
| Expensive | 106x | $140 | +19% |
Historical ranges are pointers, not guarantees.
NOVT's PE is in its fair range at 89x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over NOVT in the historical PE scenario, which offers more potential upside but is not a forecast.
NOVT Forward outlook
There aren't enough analyst estimates for NOVT to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
NOVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.32 | -9.6% |
| Q2 2026 | $1.57 | -7.1% |
| Q1 2026 | $1.39 | -29% |
| Q4 2025 | $1.47 | -17% |
| Q3 2025 | $1.46 | -12% |
| Q2 2025 | $1.69 | -1.7% |
| Q1 2025 | $1.95 | +1.6% |
| Q4 2024 | $1.77 | -12% |
NOVT's earnings per share have fallen from their peak: $1.32 over the past year, against $2.13 in mid-2023.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over NOVT on earnings, with more consistent year-over-year improvement.
NOVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $305M | +23% |
| Q2 2026 | $265.8M | +10% |
| Q1 2026 | $257.7M | +10% |
| Q4 2025 | $258.3M | +8.5% |
| Q3 2025 | $247.8M | +1.4% |
| Q2 2025 | $241M | +2.2% |
| Q1 2025 | $233.4M | +1.1% |
| Q4 2024 | $238.1M | +13% |
NOVT's revenue has grown year over year for 11 quarters in a row: $305M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.6% | -4.3 points |
| Q2 2026 | 6.8% | +0.6 points |
| Q1 2026 | 11% | -3.2 points |
| Q4 2025 | 9.6% | -1.6 points |
| Q3 2025 | 8.8% | -4.5 points |
| Q2 2025 | 6.2% | -4.7 points |
| Q1 2025 | 14% | +2.8 points |
| Q4 2024 | 11% | +1 points |
NOVT's operating margin was 4.6% last quarter, down 4.3 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over NOVT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over NOVT on profitability, with a higher operating margin.
NOVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30.4M | +621% |
| Q2 2026 | $57.5M | +392% |
| Q1 2026 | $47.5M | +73% |
| Q4 2025 | $5.1M | -91% |
| Q3 2025 | $4.2M | -78% |
| Q2 2025 | $11.7M | -68% |
| Q1 2025 | $27.4M | +3.7% |
| Q4 2024 | $59.3M | +81% |
NOVT's free cash flow has been positive every quarter for seven years: $140M over the past year, up 37% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over NOVT on cash flow, with more consistent year-over-year improvement.
NOVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +1.5M shares |
| 1 year | +19% | +6.7M shares |
| 3 years | +19% | +6.7M shares |
| 5 years | +19% | +6.9M shares |
| Available history | +20% | +7.2M shares |
NOVT has 43M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $18.6M |
| Q4 2025 | $19.1M |
| Q3 2025 | $14.1M |
| Q2 2025 | — |
| Q1 2025 | $6.2M |
| Q4 2022 | — |
NOVT spent $38M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over NOVT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
NOVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q2 2026 | -3.2x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.8x | Healthy |
NOVT's net debt is about 4.3 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over NOVT on leverage, with a lower net debt burden relative to earnings.
NOVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 18.1 | Oversold |
NOVT's weekly RSI is 39 (neutral) and its Stochastic is 18 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
NOVT PE vs Technology Sector
| Metric | NOVT | Sector median | Relative |
|---|---|---|---|
| PE | 89x | 28x | 219% above |
| PE % | 55 | 35 | 20 pts above |
NOVT is trading at 89x earnings, a 219% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over NOVT on valuation relative to its sector.
NOVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $137.8 | 15% below |
| 20 week MA | $145.1 | 19% below |
| 50 week MA | $138.9 | 15% below |
| 100 week MA | $132.3 | 11% below |
| 200 week MA | $147.5 | 20% below |
NOVT is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over NOVT on trend strength, trading above more of its moving averages.
NOVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $89.8 | $120.8 | +34% |
| 2021 | $120.8 | $173.1 | +43% |
| 2022 | $173.1 | $137.9 | -20% |
| 2023 | $137.9 | $168.4 | +22% |
| 2024 | $168.4 | $154.7 | -8.1% |
| 2025 | $154.7 | $122.7 | -21% |
| 2026 YTD | $122.7 | $117.4 | -4.3% |
NOVT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.